# Medtronic Completes $650M Acquisition of SPR Therapeutics to Expand Non-Opioid Pain Portfolio

> ma · REPORTED · 2026-07-16

On July 16, 2026, Medtronic completed its $650 million acquisition of SPR Therapeutics, a leader in short-term percutaneous peripheral nerve stimulation therapy, to expand its neuromodulation and non-opioid pain management offerings for the approximately 50 million U.S. adults living with chronic pain.

About Medtronic: Medtronic is a global healthcare technology company; SPR Therapeutics makes the SPRINT Peripheral Nerve Stimulation System, a minimally invasive, non-opioid device for chronic and acute pain management.

- Company: Medtronic
- Sector: neurotech
- Primary source: https://www.prnewswire.com/news-releases/medtronic-completes-acquisition-of-spr-expanding-patient-access-to-minimally-invasive-non-opioid-treatment-of-chronic-and-acute-pain-302827532.html

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.